madman
Super Moderator
The Optilume BPH Catheter System is a non-surgical treatment for benign prostatic hyperplasia (BPH) in aging men. It involves balloon dilation and localized transfer of paclitaxel to maintain patency. The procedure is performed using rigid cystoscopy in an office setting, without general anesthesia. Prospective data show promising functional and sexual outcomes. The article provides information about Optilume BPH, historical studies, and the deployment technique.
Key Takeaways:
Key Takeaways:
- The Optilume BPH catheter system is effective for treating various prostate glands without general anesthesia.
- It bridges the gap between conservative medical therapy and more invasive surgical procedures.
- The technology is deployable using standard cystoscopes in a urology office.
- Promising results from prospective studies and randomized controlled trials support its use.
- A standardized technique can lead to successful outcomes and be easily reproducible.
- Practitioners are advised to take time, gain experience, and confidence, and refine their technique with the new technology.